Comparable-store sales also saw an impressive gain in June, as they rose by 7.5%, however Walgreen did recognize an increase of 1.7% thanks to a calendar shift of one additional Monday and one less Sunday in June of this year versus last year. However, it also recognized a negative impact of 0.9% thanks to the increased availability of generic drugs.
There was a wide bit of variability in sales increases in the different portions of Walgreen's business. Its front-end sales at stores open at least a year increased by just 1.3%, whereas its pharmacy sales at such stores skyrocketed by 11.3%, and its prescriptions filled grew by 7.3%. The shift of the calendar resulted in a positive gain of 2.6% to its pharmacy sales.
On the negative side of things, Walgreen noted its saw a decreased amount (2%) of customer traffic the front end of its stores open at least 12 months, however it did see the average transaction increase nicely by 3.3%.
In total, June marked another impressive month for Walgreen, as in total during the 10 months thus far in its 2014 fiscal year, its sales have increased by 6%, or $3.3 billion, to $63.7 billion over 2013 levels.
Patrick Morris owns shares of Apple. The Motley Fool recommends Apple. The Motley Fool owns shares of Apple. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.